Matthias Roesslein

1.1k total citations
21 papers, 495 citations indexed

About

Matthias Roesslein is a scholar working on Materials Chemistry, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Matthias Roesslein has authored 21 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Materials Chemistry, 8 papers in Biomedical Engineering and 5 papers in Biomaterials. Recurrent topics in Matthias Roesslein's work include Nanoparticles: synthesis and applications (14 papers), Nanoparticle-Based Drug Delivery (5 papers) and Microplastics and Plastic Pollution (3 papers). Matthias Roesslein is often cited by papers focused on Nanoparticles: synthesis and applications (14 papers), Nanoparticle-Based Drug Delivery (5 papers) and Microplastics and Plastic Pollution (3 papers). Matthias Roesslein collaborates with scholars based in Switzerland, United States and Italy. Matthias Roesslein's co-authors include Peter Wick, Cordula Hirsch, Jean‐Pierre Kaiser, Harald F. Krug, Liliane Diener, Elijah J. Petersen, J.‐P. Kaiser, Tina Buerki‐Thurnherr, Bernd Nowack and Adrian Wichser and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and PLoS ONE.

In The Last Decade

Matthias Roesslein

19 papers receiving 482 citations

Peers

Matthias Roesslein
Monique Groenewold Netherlands
Frank Thielbeer United Kingdom
Christa Watson United States
Phil Sayre United States
Laura‐Jayne A. Ellis United Kingdom
Jorge Mejia Belgium
Monique Groenewold Netherlands
Matthias Roesslein
Citations per year, relative to Matthias Roesslein Matthias Roesslein (= 1×) peers Monique Groenewold

Countries citing papers authored by Matthias Roesslein

Since Specialization
Citations

This map shows the geographic impact of Matthias Roesslein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Roesslein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Roesslein more than expected).

Fields of papers citing papers by Matthias Roesslein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Roesslein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Roesslein. The network helps show where Matthias Roesslein may publish in the future.

Co-authorship network of co-authors of Matthias Roesslein

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Roesslein. A scholar is included among the top collaborators of Matthias Roesslein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Roesslein. Matthias Roesslein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerken, Lukas R. H., Matthias Roesslein, Inge K. Herrmann, & Alexander Gogos. (2025). Alternative digestion strategy for Ti, Zr and Hf oxides: eliminating hydrofluoric acid. Analytical Methods. 17(26). 5334–5342.
2.
Farkas, Natalia, John A. Kramar, Antonio R. Montoro Bustos, et al.. (2025). Derivation of Particle Number Concentration from the Size Distribution: Theory and Applications. Analytical Chemistry. 97(21). 10999–11006.
3.
Simon, Carl G., Sven Even Borgos, Luigi Calzolai, et al.. (2023). Orthogonal and complementary measurements of properties of drug products containing nanomaterials. Journal of Controlled Release. 354. 120–127. 29 indexed citations
4.
Petersen, Elijah J., Ana C. Barrios, Theodore B. Henry, et al.. (2022). Potential Artifacts and Control Experiments in Toxicity Tests of Nanoplastic and Microplastic Particles. Environmental Science & Technology. 56(22). 15192–15206. 39 indexed citations
5.
Halamoda‐Kenzaoui, Blanka, Robert E. Geertsma, Adriele Prina‐Mello, et al.. (2022). Future perspectives for advancing regulatory science of nanotechnology-enabled health products. Drug Delivery and Translational Research. 12(9). 2145–2156. 14 indexed citations
6.
Nelson, Bryant C., Caterina Minelli, Shareen H. Doak, & Matthias Roesslein. (2020). Emerging Standards and Analytical Science for Nanoenabled Medical Products. Annual Review of Analytical Chemistry. 13(1). 431–452. 9 indexed citations
7.
Halamoda‐Kenzaoui, Blanka, Merel van Elk, Robert E. Geertsma, et al.. (2020). Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products. SHILAP Revista de lepidopterología. 3(2). 14 indexed citations
8.
Petersen, Elijah J., Antonio R. Montoro Bustos, Blaza Toman, et al.. (2019). Determining what really counts: modeling and measuring nanoparticle number concentrations. Environmental Science Nano. 6(9). 2876–2896. 31 indexed citations
9.
Roesslein, Matthias, et al.. (2019). Anticipation of regulatory needs for nanotechnology-enabled health products. DORA Empa (Swiss Federal Laboratories for Materials Science and Technology (Empa)). 10 indexed citations
10.
Petersen, Elijah J., Cordula Hirsch, John T. Elliott, et al.. (2019). Cause-and-Effect Analysis as a Tool To Improve the Reproducibility of Nanobioassays: Four Case Studies. Chemical Research in Toxicology. 33(5). 1039–1054. 29 indexed citations
11.
Kaiser, Jean‐Pierre, Matthias Roesslein, Liliane Diener, et al.. (2017). Cytotoxic effects of nanosilver are highly dependent on the chloride concentration and the presence of organic compounds in the cell culture media. Journal of Nanobiotechnology. 15(1). 5–5. 47 indexed citations
12.
Wick, Peter, Savvina Chortarea, Olivier T. Guenat, et al.. (2015). In vitro-ex vivo model systems for nanosafety assessment. DORA Empa (Swiss Federal Laboratories for Materials Science and Technology (Empa)). 7(3). 169–179. 20 indexed citations
13.
Kaiser, Jean‐Pierre, Matthias Roesslein, Liliane Diener, & Peter Wick. (2013). Human Health Risk of Ingested Nanoparticles That Are Added as Multifunctional Agents to Paints: an In Vitro Study. PLoS ONE. 8(12). e83215–e83215. 43 indexed citations
14.
Roesslein, Matthias, Cordula Hirsch, Jean‐Pierre Kaiser, Harald F. Krug, & Peter Wick. (2013). Comparability of in Vitro Tests for Bioactive Nanoparticles: A Common Assay to Detect Reactive Oxygen Species as an Example. International Journal of Molecular Sciences. 14(12). 24320–24337. 74 indexed citations
15.
Hirsch, Cordula, Tina Buerki‐Thurnherr, Lisong Xiao, et al.. (2012). A comprehensive evaluation platform to assess nanoparticle toxicity in vitro. Toxicology Letters. 211. S41–S41. 1 indexed citations
16.
Kaiser, J.‐P., Matthias Roesslein, Tina Buerki‐Thurnherr, & Peter Wick. (2011). Carbon Nanotubes – Curse or Blessing. Current Medicinal Chemistry. 18(14). 2115–2128. 36 indexed citations
17.
Hirsch, Cordula, et al.. (2011). A novel comprehensive evaluation platform to assess nanoparticle toxicityin vitro. Journal of Physics Conference Series. 304. 12053–12053. 10 indexed citations
18.
Hirsch, Cordula, Matthias Roesslein, Harald F. Krug, & Peter Wick. (2011). Nanomaterial Cell Interactions: Are Current In Vitro Tests Reliable?. Nanomedicine. 6(5). 837–847. 52 indexed citations
19.
Roesslein, Matthias, et al.. (2007). A forgotten fact about the standard deviation. Accreditation and Quality Assurance. 12(9). 495–496. 13 indexed citations
20.
Wegscheider, Wolfhard, et al.. (2002). The Role of Validation in Traceability. 17. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026